Bovopoulos Andreas has filed a Schedule 13G/A with the SEC, reporting a beneficial ownership of approximately 6.9% in Cosmos Health Inc. This significant stake, amounting to 6,930,412.30 shares, positions Bovopoulos as a notable shareholder in the company.

This filing is important as it highlights Bovopoulos' ongoing interest in Cosmos Health, a player in the wholesale drugs industry. The disclosure may influence how other companies in this sector strategize and compete.

Background

Cosmos Health Inc. is incorporated in Nevada and operates primarily in the wholesale drugs sector. The company has undergone name changes in the past, previously known as Cosmos Holdings Inc. and Prime Estates & Developments Inc. Cosmos Health's principal executive office is located in Thessaloniki, Greece.

What the Filing Says

The filing states that Bovopoulos beneficially owns 6,930,412.30 shares of Cosmos Health, representing about 6.887% of the total shares outstanding, which is reported to be 100,633,773 shares. The filing also affirms that these shares were not acquired for the purpose of changing or influencing control of the issuer.

Impact

This disclosure may affect various stakeholders, including other investors and competitors within the wholesale drugs industry. As Bovopoulos holds a significant percentage of shares, it could lead to increased scrutiny of Cosmos Health's operations and future strategies.

What's Next

The filing does not say what happens next.